List of Excipients in API ESTAZOLAM
✉ Email this page to a colleague
Excipients in ANDA-approved (generic) drugs containing ESTAZOLAM
| Company | Ingredient | NDC | Excipient |
|---|---|---|---|
| Actavis Pharma Inc | estazolam | 0591-0744 | CELLULOSE, MICROCRYSTALLINE |
| Actavis Pharma Inc | estazolam | 0591-0744 | DOCUSATE SODIUM |
| Actavis Pharma Inc | estazolam | 0591-0744 | LACTOSE MONOHYDRATE |
| >Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for ESTAZOLAM
Excipient focus: ALUMINUM OXIDE
ESTAZOLAM drug variants containing ALUMINUM OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Rebel Distributors Corp | estazolam | 21695-220 |
| >Company | >Ingredient | >NDC |
ESTAZOLAM drug variants not containing ALUMINUM OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | estazolam | 0591-0744 |
| Mayne Pharma | estazolam | 51862-069 |
| Mayne Pharma | estazolam | 51862-073 |
| >Company | >Ingredient | >NDC |
Excipient focus: ANHYDROUS LACTOSE
ESTAZOLAM drug variants containing ANHYDROUS LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| Novitium Pharma LLC | estazolam | 70954-480 |
| >Company | >Ingredient | >NDC |
ESTAZOLAM drug variants not containing ANHYDROUS LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | estazolam | 0591-0744 |
| Rebel Distributors Corp | estazolam | 21695-220 |
| Mayne Pharma | estazolam | 51862-069 |
| >Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
ESTAZOLAM drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | estazolam | 0591-0744 |
| Rebel Distributors Corp | estazolam | 21695-220 |
| >Company | >Ingredient | >NDC |
ESTAZOLAM drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Mayne Pharma | estazolam | 51862-069 |
| Mayne Pharma | estazolam | 51862-073 |
| Novitium Pharma LLC | estazolam | 70954-480 |
| >Company | >Ingredient | >NDC |
Excipient focus: DOCUSATE SODIUM
ESTAZOLAM drug variants containing DOCUSATE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | estazolam | 0591-0744 |
| Rebel Distributors Corp | estazolam | 21695-220 |
| >Company | >Ingredient | >NDC |
ESTAZOLAM drug variants not containing DOCUSATE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Mayne Pharma | estazolam | 51862-069 |
| Mayne Pharma | estazolam | 51862-073 |
| Novitium Pharma LLC | estazolam | 70954-480 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C RED NO. 40
ESTAZOLAM drug variants containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| Rebel Distributors Corp | estazolam | 21695-220 |
| >Company | >Ingredient | >NDC |
ESTAZOLAM drug variants not containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | estazolam | 0591-0744 |
| Mayne Pharma | estazolam | 51862-069 |
| Mayne Pharma | estazolam | 51862-073 |
| >Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
ESTAZOLAM drug variants containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | estazolam | 0591-0744 |
| Rebel Distributors Corp | estazolam | 21695-220 |
| Mayne Pharma | estazolam | 51862-069 |
| >Company | >Ingredient | >NDC |
ESTAZOLAM drug variants not containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
ESTAZOLAM drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | estazolam | 0591-0744 |
| Rebel Distributors Corp | estazolam | 21695-220 |
| Novitium Pharma LLC | estazolam | 70954-480 |
| >Company | >Ingredient | >NDC |
ESTAZOLAM drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Mayne Pharma | estazolam | 51862-069 |
| Mayne Pharma | estazolam | 51862-073 |
| Dr Reddy's Labratories Inc | estazolam | 75907-028 |
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
ESTAZOLAM drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Novitium Pharma LLC | estazolam | 70954-480 |
| >Company | >Ingredient | >NDC |
ESTAZOLAM drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | estazolam | 0591-0744 |
| Rebel Distributors Corp | estazolam | 21695-220 |
| Mayne Pharma | estazolam | 51862-069 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM BENZOATE
ESTAZOLAM drug variants containing SODIUM BENZOATE
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | estazolam | 0591-0744 |
| Rebel Distributors Corp | estazolam | 21695-220 |
| >Company | >Ingredient | >NDC |
ESTAZOLAM drug variants not containing SODIUM BENZOATE
| Company | Ingredient | NDC |
|---|---|---|
| Mayne Pharma | estazolam | 51862-069 |
| Mayne Pharma | estazolam | 51862-073 |
| Novitium Pharma LLC | estazolam | 70954-480 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
ESTAZOLAM drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | estazolam | 0591-0744 |
| Rebel Distributors Corp | estazolam | 21695-220 |
| >Company | >Ingredient | >NDC |
ESTAZOLAM drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
| Company | Ingredient | NDC |
|---|---|---|
| Mayne Pharma | estazolam | 51862-069 |
| Mayne Pharma | estazolam | 51862-073 |
| Novitium Pharma LLC | estazolam | 70954-480 |
| >Company | >Ingredient | >NDC |
Excipient focus: STARCH, CORN
ESTAZOLAM drug variants containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| Mayne Pharma | estazolam | 51862-069 |
| Mayne Pharma | estazolam | 51862-073 |
| Novitium Pharma LLC | estazolam | 70954-480 |
| >Company | >Ingredient | >NDC |
ESTAZOLAM drug variants not containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | estazolam | 0591-0744 |
| Rebel Distributors Corp | estazolam | 21695-220 |
| >Company | >Ingredient | >NDC |
Excipient focus: STEARIC ACID
ESTAZOLAM drug variants containing STEARIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | estazolam | 0591-0744 |
| Rebel Distributors Corp | estazolam | 21695-220 |
| Mayne Pharma | estazolam | 51862-069 |
| >Company | >Ingredient | >NDC |
ESTAZOLAM drug variants not containing STEARIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Novitium Pharma LLC | estazolam | 70954-480 |
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
